US2015183736A1PendingUtilityA1
Cyanine-containing compounds for cancer imaging and treatment
Est. expiryJul 13, 2027(~1 yrs left)· nominal 20-yr term from priority
Inventors:Leland W.K. ChungLucjan StrekowskiChunmeng ShiMaged HenaryGabor PatonayJames J. KrutakXiaojian YangGuodong ZhuRuoxiang WangHaiyen E. Zhau
C07D 209/10A61P 35/00A61K 31/404C07D 209/92C07D 209/60A61K 49/00G01N 33/5008
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention relates generally to cyanine-containing compounds; pharmaceutical compositions comprising cyanine-containing compounds; and methods of using cyanine-containing compounds for cancer cell imaging, cancer cell growth inhibition, and detecting cancer cells, for example. Compounds of the invention are preferentially taken up by cancer cells as compared to normal cells. This allows many uses in the cancer treatment, diagnosis, tracking and imaging fields.
Claims
exact text as granted — not AI-modified1 . A compound having formula:
where X is selected from the group consisting of: hydrogen, halogen, CN, Me, phenyl, OH, OMe, OPh, 4-O-Ph-NH 2 , 4-O-Ph-CH 2 CH 2 COOH, 4-O-Ph-CH 2 CH 2 CONHS, NH-Ph, NHEt, SEt, S-Ph, 4-S-Ph-COOH, 4-S-Ph-OH, 4-O-Ph-COOH, 4-O-Ph-NCS, and 4-S-Ph-NCS; q is 0 or 1; R 7 is selected from H and COOR 9 , where R 9 is H, CH 3 , or CH 2 CH 3 ; each R 1 is independently in each instance, (CH2)mR A , where m is an integer from 1 to 12, R A is independently CH3, NH2, SH, COOH, SO3H, OH, halogen and CO—N-hydroxysuccinimide; each R 10 is independently in each instance selected from H, OH, OMe, halogen, NH 2 , NHR, NR 2 and COOH, where each R is independently C1-C6 alkyl; each R 3 is independently in each instance, selected from the group consisting of: methyl and phenyl.
2 - 30 . (canceled)Join the waitlist — get patent alerts
Track US2015183736A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.